Download FREE Report Sample
Download Free sampleMelanoma is a type of skin cancer developing from pigment-containing cells known as melanocytes. Melanoma cancer diagnostics is to diagnose melanoma with biopsy. During a biopsy, all or the part of mole or growth over the skin is removed to test and analyze the sample. Common biopsy procedures used to diagnose melanoma are punch biopsy, incisional biopsy, and excisional biopsy.
Melanoma Cancer Diagnostics Market contains market size and forecasts of Melanoma Cancer Diagnostics in Global, including the following market information:
Global Melanoma Cancer Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Melanoma Cancer Diagnostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Fluorescent In Situ Hybridization (FISH) Tests Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Melanoma Cancer Diagnostics include AB Sciences, Incyte, Merck, Novartis, Pierre Fabre, Amgen, AstraZeneca, Bristol-Myers Squibb and Daiichi Sankyo. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Melanoma Cancer Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Melanoma Cancer Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Melanoma Cancer Diagnostics Market Segment Percentages, by Type, 2021 (%)
Fluorescent In Situ Hybridization (FISH) Tests
Comparative Genomic Hybridization (CGH) Tests
Immunohistochemical (IHC) Tests
Global Melanoma Cancer Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Melanoma Cancer Diagnostics Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Cancer Research Centres
Others
Global Melanoma Cancer Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Melanoma Cancer Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Melanoma Cancer Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Melanoma Cancer Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AB Sciences
Incyte
Merck
Novartis
Pierre Fabre
Amgen
AstraZeneca
Bristol-Myers Squibb
Daiichi Sankyo
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
